Will Myriad's Marketing to Mammogram Centers Ease or Fan Over-Testing Concerns with BRACAnalysis?

Under the partnership with MRS, Myriad is hoping for "greater penetration into the asymptomatic market -- women who do not have breast or ovarian cancer but have a family history."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.